Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artemis Medicare ServicesBOM:542919 -3.14%87 Return-on-Tangible-Equity is 13.64% as of Mar. 2026, which is 14% above its 10-year median of 11.97. GuruFocus rates BOM:542919 with a GF Score™ of 87/100 and a GF Value™ of ₹265.89 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Artemis Medicare Services ranks better than 54.17% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Artemis Medicare Services's annualized net income for the quarter that ended in Mar. 2026 was ₹1,201 Mil. Artemis Medicare Services's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹8,808 Mil. Therefore, Artemis Medicare Services's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 13.64%.
The historical rank and industry rank for Artemis Medicare Services's Return-on-Tangible-Equity or its related term are showing as below:
BOM:542919'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.38 Med: 11.97 Max: 13.95
Current: 12.45
During the past 12 years, Artemis Medicare Services's highest Return-on-Tangible-Equity was 13.95%. The lowest was 2.38%. And the median was 11.97%.
BOM:542919's Return-on-Tangible-Equity is ranked better than 54.17% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.605
vs BOM:542919: 12.45
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Artemis Medicare Services Return-on-Tangible-Equity Related Terms
Artemis Medicare Services Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Artemis Medicare Services's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542919 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Artemis Medicare Services's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artemis Medicare Services Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artemis Medicare Services's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Artemis Medicare Services's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.64% mean?
Artemis Medicare Services (BOM:542919) has a Return-on-Tangible-Equity of 13.64% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Artemis Medicare Services and its competitors. This is 14% above median its historical median of 11.97. Over the past decade, Artemis Medicare Services' Return-on-Tangible-Equity has ranged from 2.38 to 13.95. According to the industry distribution chart, Artemis Medicare Services ranks #264 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 45.8%.
Is Artemis Medicare Services' Return-on-Tangible-Equity too high?
Artemis Medicare Services' current Return-on-Tangible-Equity of 13.64% is 14% above median its 10-year median of 11.97. Over the past 10 years, this metric has ranged from a low of 2.38 to a high of 13.95. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.61. Artemis Medicare Services' value of 13.64% is 28.6% above this industry median. Based on the distribution chart, Artemis Medicare Services ranks #264 out of 576 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Artemis Medicare Services has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artemis Medicare Services' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artemis Medicare Services ranks #264 out of 576 companies for Return-on-Tangible-Equity. This puts Artemis Medicare Services in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.61. Artemis Medicare Services' value of 13.64% is 28.6% above this benchmark. Historically, Artemis Medicare Services' own Return-on-Tangible-Equity has ranged from 2.38 to 13.95 over the past decade. While the company's 10-year median is 11.97 vs. the industry median of 10.61, Artemis Medicare Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.61, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artemis Medicare Services's current Return-on-Tangible-Equity of 13.64% is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Artemis Medicare Services and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artemis Medicare Services's current Return-on-Tangible-Equity is 13.64%, which is 14% above median its own 10-year median of 11.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artemis Medicare Services stock overvalued right now?
Based on GuruFocus' analysis, Artemis Medicare Services (BOM:542919) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹265.89, compared to a current price of ₹311.80 — trading 17.3% above its estimated fair value. The current Return-on-Tangible-Equity is 13.64%, which is 14% above median its 10-year median of 11.97 and 28.6% above the Healthcare Providers & Services industry median of 10.61. Artemis Medicare Services' overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Artemis Medicare Services (BOM:542919), the current Return-on-Tangible-Equity is 13.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artemis Medicare Services (BOM:542919) Overvalued in 2026?
Based on GuruFocus' analysis, Artemis Medicare Services stock appears to be overvalued.
The current stock price of ₹311.80 is trading 17.3% above its estimated GF Value™ of ₹265.89.
GuruFocus considers Artemis Medicare Services to be Modestly Overvalued.
Key valuation signals for BOM:542919:
Return-on-Tangible-Equity: 13.64% (14% above median its 10-year median of 11.97)
GF Value™: ₹265.89 vs. price of ₹311.80 (17.3% above fair value)
Industry Position: 28.6% above the Healthcare Providers & Services median (#264 of 576)
No single metric tells the full story. See the BOM:542919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artemis Medicare Services Ltd is engaged in managing and operating multi-specialty hospitals. The hospital provides treatments for Allergy and Immunology, Blood (Haematology), Bones, Muscles and Joints (Orthopaedics), Brain, Spine and Nervous System, Cancer (Oncology), Circulatory (Vascular), Digestive (Gastroenterology), Endocrine, Diabetes And Metabolism, Dermatology, Heart (Cardiology), Infectious Diseases, Kidneys (Renal), Lung (Pulmonary), Mouth, Teeth And Face (Oral And Maxillofacial), Obstetrics And Gynecology, Psychiatry, Rheumatology (Arthritis And Joint Disease), Surgery, and Urology. The company derives revenue mainly from Healthcare Services through the operation of multi-specialty Hospitals.
87GF Score
Get the complete analysis for BOM:542919
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542919 has been successfully added to your 
